Last updated: 2026-09-30 15:18:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
NewGenIvf Group Limited (NIVF) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0,18, with a market capitalization of $833,53K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,06 to $1.539,00. This page covers its latest market performance, valuation, price trends and company information.
$833,53K | |
$0,17 | |
$1.771.200,00 | |
$0,06 | |
$0,07 | |
673,46M | |
1,44M | |
-- | |
$1.539,00 | |
$0,06 | |
-- | |
-- |
NewGenIvf Group Limited (NIVF) is currently trading at $0,18 as of 2026-09-30 15:02:50, up 147,22% ($0,11) from the previous close of $0,07
During today's regular trading session, NIVF has traded between $0,06 and $1.771.200,00, with a trading volume of 673,46M shares. The current price is near the lower end of today's range.
Over the past seven days, NewGenIvf Group Limited (NIVF) moved from $0,72 to $0,18, representing a decline of 75,28% ($0,54).
The stock traded between $0,06 and $0,90 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 11,71 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0,0%
NIVF is currently trading at $0,18, placing it 0,0% of the way from its 52-week low of $0,06 to its 52-week high of $1.539,00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
| Employees | 87 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of NewGenIvf Group Limited (NIVF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.